Regencell Bioscience (RGC) had the highest return last year by a large-cap US stock, returning 15,618.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 2025 | 15,618.56% |
EchoStar (SATS) | 2025 | 369.75% |
Lumentum (LITE) | 2025 | 337.96% |
Sibanye Gold Ltd ADR (SBSW) | 2025 | 317.89% |
Bloom Energy (BE) | 2025 | 286.01% |
Hecla Mining (HL) | 2025 | 284.71% |
Western Digital (WDC) | 2025 | 282.32% |
AngloGold Ashanti (AU) | 2025 | 277.7% |
IREN (IREN) | 2025 | 266.34% |
Ast Spacemobile (ASTS) | 2025 | 243.57% |
Oklo (OKLO) | 2025 | 238.01% |
Micron Technology (MU) | 2025 | 236.96% |
Guardant Health (GH) | 2025 | 226.85% |
Gold Fields Ltd ADR (GFI) | 2025 | 225.85% |
Seagate Technology (STX) | 2025 | 221.91% |
Celestica (CLS) | 2025 | 218.44% |
D-Wave Quantum (QBTS) | 2025 | 207.65% |
Coeur Mining (CDE) | 2025 | 204.27% |
Kinross Gold (KGC) | 2025 | 202.52% |
Nebius (NBIS) | 2025 | 197.56% |
Robinhood Markets (HOOD) | 2025 | 193.46% |
Kratos Defense & Security Solutions (KTOS) | 2025 | 187.86% |
BridgeBio Pharma (BBIO) | 2025 | 175.24% |
Ciena (CIEN) | 2025 | 174.91% |
Rocket Lab USA (RKLB) | 2025 | 174.32% |
Large-cap stocks are treated as having a market cap of $10B+.
